![Gerrit Hauck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 652 192 $ al 31/05/2026
Dr. Gerrit Hauck is a Chief Technology Officer at Basilea Pharmaceutica AG.
He is on the Board of Directors at Basilea Pharmaceutica China Ltd. He received his undergraduate degree from Ruprecht-Karls-Universität Heidelberg and a doctorate degree from Universität des Saarlandes.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BASILEA PHARMACEUTICA AG 0,07 % | 31/12/2025 | 9.781 ( 0,07 % ) | 652 192 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Director Técnico/Científico/I+D | 01/05/2018 |
Basilea Pharmaceutica China Ltd.
 Basilea Pharmaceutica China Ltd. Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of anti-infective and anti-cancer drugs | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Basilea Pharmaceutica AG
 Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universität des Saarlandes
 Universität des Saarlandes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Basilea Pharmaceutica China Ltd.
Basilea Pharmaceutica China Ltd. Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of anti-infective and anti-cancer drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
